Baqsimi™ (glucagon) nasal powder

3mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

BAQSIMI™ (glucagon) nasal powder: Position After Administration

It is recommended to turn the person on their side after administering Baqsimi (glucagon nasal powder).

Detailed Information

If the person is unconscious, it is recommended to turn the person on their side after administering the dose of Baqsimi.1

Enclosed Prescribing Information

BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly

Reference

1. Baqsimi [instructions for use]. Indianapolis, IN: Eli Lilly and Company; 2019.

Glossary

Baqsimi = Baqsimi™ (glucagon) nasal powder

Date of Last Review: July 24, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical